Sustainable Household Energy Adoption in Rwanda (SHEAR) (SHEAR)

January 14, 2026 updated by: Colorado State University

Sustainable Household Energy Adoption in Rwanda (SHEAR): Promoting Rural Health With Solar and Natural Gas

Investigators will conduct a randomized controlled trial substituting traditional forms of household energy (biomass for cooking and kerosene for lighting) with liquified petroleum gas (LPG) stoves/fuel and solar power (in areas marker for solar grids by the Government of Rwanda) in rural Rwanda. Eligible households (n=650) using traditional forms of energy will be recruited from eastern Rwanda. In each household, investigators will recruit either one adult female and one adult male or just one adult, and one child (aged 8-15 years). Following baseline health and exposure assessment, a randomized treatment arm (n=250 homes) will receive a full subsidy for LPG fuel and solar power, a control arm (n=250 homes) will continue to use traditional energy, and a random-subsidy arm (n=150 homes) will be randomized to a discounted price (at baseline and every 6-months) for solar and LPG in a pay-as-you-go (PAYG) service model (i.e., pre-pay a desired amount through mobile money). The random subsidy arm will then decide whether or not to cook with the discounted LPG or their traditional stove. Participants will be followed for 3 years with repeated measures of household air pollution (HAP) exposure (48-hour fine particulate matter (PM2.5) and black carbon (BC)), energy use, health, and preferences. Primary health endpoints include blood pressure (BP) in adults and lung-function growth in children; secondary endpoints include BP in children and lung-function change in adults. To complement the trial, the random-subsidy arm will generate policy-relevant information on causal relationships between energy costs, solar and LPG usage, and HAP exposures. The investigators propose 3 aims:

Aim 1. In an ITT framework, investigators will evaluate the effect of a household energy intervention on exposure to HAP and indicators of morbidity separately among Rwandan women, men, and children within n=500 households.

Aim 2. Using exposure-response modeling, investigators will characterize associations between exposure to HAP and indicators of morbidity separately among Rwandan women, men, and children within n=650 households (500 trial households + 150 random subsidy households).

Aim 3. Using a random-encouragement design, investigators will investigate causal relationships between randomized energy costs, measured energy usage, and estimated exposure to HAP among n=400 households (150 random subsidy households + 250 full subsidy treatment arm households).

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

1680

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Eastern Province
      • Ndego, Eastern Province, Rwanda, 80521
        • Field site in Rwanda (Isangano and Karambi)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

This research will recruit and enroll 650 households (250 households in the full subsidy arm; 250 households in the control arm; 150 households in the discount subsidy arm).

The household level inclusion criteria is as follows:

  • Home resides in the study area of Isangano and Karambi
  • Uses biomass as primary cooking fuel
  • Either both an adult male (at least 18 years old) and female (at least 18 years old), or just one adult (at least 18 years old), head(s) of household willing to consent and at least one child between 8 and 15 years of age willing to assent; We will recruit the younger child in families with more than one child between 8-15 years of age. We will also confirm the child is living at home throughout the year and not attending boarding school elsewhere.
  • No commercial cooking
  • No smoking in the household

Additional participant level inclusion is as follows:

  • Not planning to move in 3-year timeframe
  • Not currently pregnant (females); Note: If the female becomes pregnant during the study she will not be able to participate in any visits that occur during her pregnancy but she will be able to participate after she has given birth. However, if there is another adult in the household then this will not preclude the other two people (i.e., the other adult and the child) from continuing to participate throughout that time.

Exclusion Criteria:

The household level exclusion criteria is as follows:

  • Home resides outside the study area
  • Uses clean fuel as primary cooking fuel
  • Participants outside the age ranges: Adult male (at least 18 years old) and female (at least 18 years old) heads of household willing to consent and at least one child between 8 and 15 years of age willing to assent
  • Conducts commercial cooking
  • Smoking members of the household

Additional participant level exclusion is as follows:

  • Planning to move in 3-year timeframe
  • Currently pregnant (females)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Full Subsidy Arm
This arm receives free LPG and stove for cooking following the baseline measures, for the duration of the 3-year follow-up period. For those households in Government of Rwanda designated areas for solar microgrids, this arm will also be connected to and provided free access to solar electricity for lighting.
LPG stoves/fuel for cooking and solar electricity for lighting
No Intervention: Control Arm
This arm will remain using traditional forms of energy for cooking and lighting.
Experimental: Discount Subsidy Arm
This arm will be randomized to a discounted price (at baseline and every 6-months during the 3-year study) for solar electricity (in areas marker for solar grids by the Government of Rwanda) and LPG gas in a pay-as-you-go (PAYG) service model (i.e., pre-pay an affordable amount through mobile money, a common form of currency transactions in Rwanda). For example, this arm will be asked to cook as normal and decide whether or not to cook with the discounted LPG or their traditional stove (i.e., they will not be required to pay for LPG).
LPG stoves/fuel for cooking and solar electricity for lighting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in systolic blood pressure (adults)
Time Frame: Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): FEV1 trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): FVC trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry will be measured approx. every 6 months for the 3-year follow-up period

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in systolic blood pressure (children)
Time Frame: Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Change in diastolic blood pressure (children)
Time Frame: Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): FEV1/FVC trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): FEF25-75 trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (children): PEF trajectory
Time Frame: Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Spirometry will be measured approx. every 6 months for the 3-year follow-up period
Change in diastolic blood pressure (adults)
Time Frame: Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Blood pressure will be measured approx. every 6 months for the 3-year follow-up period
Spirometry (adults): FEV1 change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Spirometry (adults): FVC change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Spirometry (adults): FEV1/FVC change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Spirometry (adults): FEF25-75 change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Spirometry (adults): PEF change
Time Frame: Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).
Lung function will be measured approx. every 1 year for the 3-year follow-up period (adults).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 17, 2022

Primary Completion (Actual)

August 22, 2025

Study Completion (Actual)

August 22, 2025

Study Registration Dates

First Submitted

December 7, 2022

First Submitted That Met QC Criteria

December 19, 2022

First Posted (Actual)

December 30, 2022

Study Record Updates

Last Update Posted (Actual)

January 15, 2026

Last Update Submitted That Met QC Criteria

January 14, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2219
  • R01ES029995 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Pressure

Clinical Trials on Clean household energy

Subscribe